In a glioblastoma, Kim et al. describe PDK4 regulation through NF-κB activation of PGC1α (Kim et al. 2015), and NF-κB signaling is altered in the LCC9 model of acquired SERM resistance (Riggins et al. 2005). Here, NFKB1 is linked to glioblastoma.